Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination (2021)
Attributed to:
A One Health approach to pan-valent morbillivirus vaccines
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.06.23.21259327
Publication URI: http://dx.doi.org/10.1101/2021.06.23.21259327
Type: Preprint